Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
SAN DIEGO, CA / August 7, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch the next generation of easy-to-use, prescribe and live with affordable insulin pump technology,...
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
DUBLIN, Aug. 06, 2024 -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, obtained an extension to demonstrate compliance with a continued...
Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs
PONTE VEDRA, Fla., Aug. 6, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart...
Reviva Announces Grant of U.S. Patent Covering Use of Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis
CUPERTINO, Calif., Aug. 06, 2024 -- -Similar patent has also been granted in Japan -Brilaroxazine has received Orphan Drug Designation for the treatment of idiopathic pulmonary fibrosis (IPF) Cupertino, Calif., August 6, 2024 - Reviva Pharmaceuticals Holdings, Inc....
Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
Encinitas, California--(August 6, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (KPRX) ("Kiora" or the "Company"), will participate in two upcoming conferences that will be available to investors by live webcast. On Tuesday August 13th, 2024 at 3:00 pm Eastern...
InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
CARMEL, Ind., Aug. 05, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized...
ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Interim Chief Financial Officer, James Lee, will...
Dror Ortho-Design, Inc. Launches ZSMILE User Experience Trial
JERUSALEM, Aug. 05, 2024 -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a...
InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience
-Second Quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over year growth- -Reiterating financial guidance of approximately $20 million of annualized run-rate EBITDASO1 on annualized run-rate revenues of...
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
Funding Extends Company's Cash Runway into Second Quarter 2025, which is beyond the Anticipated Timing for SHIELD II Top-line Results if Warrants are Fully Exercised More than 300 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of...
SenesTech to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 1, 2024 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on...
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Reports record revenue of $17.9 million for the second quarter of 2024, an increase of 11.2 percent over the comparable period 2023.Reports GAAP diluted EPS of $0.38 and non-GAAP diluted EPS of $0.42 for the second quarter of 2024.Reports second quarter of 2024...
LiqTech Enters MoU with China Haisum Engineering Co. Ltd. for Industrial Water Treatment Applications in China
BALLERUP, Denmark and SHANGHAI, China, Aug. 1, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and systems, and China Haisum Engineering Co., Ltd., a one-stop...
Jewett-Cameron Lists 11.6 acre Property for Sale
NORTH PLAINS, Ore., July 31, 2024 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) listed their 11.6 acre property at 31345 NW Beach Rd, Hillsboro, OR 97124, for sale on July 29, 2024. The property is a corner lot industrial property with excellent access,...
Zoomd Recognized as Top User Acquisition Company for 2024
VANCOUVER, BC, July 31, 2024 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, is delighted to announce...
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024
PETACH TIKVA, Israel, July 31, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2024 financial results and operational...
Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies
Encinitas, California--(July 30, 2024) - Kiora Pharmaceuticals (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it has received Orphan Medicinal Product Designation from the European Medicines Agency (EMA) for the treatment of a group of inherited retinal...
Mogo to Announce Q2 2024 Financial Results August 8, 2024
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital wealth and payments business, today announced it will hold a conference call and webcast to discuss its Q2 2024 financial results on Thursday, August 8, 2024 at 1:00...
GSE Solutions to Attend ANS UWC Conference 2024
GSE Solutions shows continual commitment to backing the American Nuclear Society by being a Gold Sponsor, with the presence of their new Chief Executive Officer and Chief Operating Officer COLUMBIA, Md., July 29, 2024 -- GSE Solutions ("GSE Systems, Inc." or "GSE")...
LiqTech and Danbee Marine Co. Ltd. Enter Agreement for Marine Scrubber Water Treatment Solutions for the South Korean Market
BALLERUP, Denmark, July 25, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and systems for marine, and Danbee Marine, a South Korean-based maritime representative...
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
Winter Springs, Fla., July 25, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, August 1, 2024. Iradimed management will host a conference call the...
LiqTech International to Discuss Second Quarter 2024 Results on Wednesday, August 14, 2024
Management to Host Conference Call on Wednesday, August 14, 2024, at 9:00 a.m. ET BALLERUP, Denmark, July 24, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and...
ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will hold a conference call on Wednesday, August 7, 2024 at 4:30 p.m. ET to discuss its financial...